Anvyl Competitors and Similar CompaniesClear all
Anvyl's competitors and similar companies include CSL Behring and UCB.
 Anvyl Anvyl is a company developing therapies for the treatment of cognitive-deficit disorders and other disorders of the central nervous system (CNS). |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date N/A | Founding Date 1904 | Founding Date 1928 |
Type | Type Private | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 3 | Employees 7,5692% decrease | Employees 9,052 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €7.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit €7.2b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 100 (Dec, 2020) | Countries 35 (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company